TY - JOUR
T1 - An assay to detect glycoproteins that contain mannose 6-phosphate
AU - Valenzano, Kenneth J.
AU - Kallay, Laura M.
AU - Lobel, Peter
PY - 1993/2/15
Y1 - 1993/2/15
N2 - We have developed a broadly applicable solid phase assay for quantitative and qualitative analysis of phosphorylated lysosomal enzymes and other glycoproteins that contain mannose 6-phosphate (Man6-P) residues. Samples are immobilized on membranes and proteins that contain Man6-P are detected using an iodinated, soluble form of the cation-independent Man6-P receptor. The assay is highly specific, sensitive, and linear over 3 orders of magnitude. The technique has two general applications. First, it can be used in a dot blot format to analyze large numbers of samples for total levels of Man6-P glycoproteins. Second, it can be used in a western blot format to identify Man6-P glycoproteins that have been fractionated by polyacrylamide gel electrophoresis. Specific applications of this novel assay include structural characterization of glycoproteins, diagnosis of mucolipidosis II and III, and screening of pharmaceuticals for lysosomotropic activity. Other potential applications are discussed.
AB - We have developed a broadly applicable solid phase assay for quantitative and qualitative analysis of phosphorylated lysosomal enzymes and other glycoproteins that contain mannose 6-phosphate (Man6-P) residues. Samples are immobilized on membranes and proteins that contain Man6-P are detected using an iodinated, soluble form of the cation-independent Man6-P receptor. The assay is highly specific, sensitive, and linear over 3 orders of magnitude. The technique has two general applications. First, it can be used in a dot blot format to analyze large numbers of samples for total levels of Man6-P glycoproteins. Second, it can be used in a western blot format to identify Man6-P glycoproteins that have been fractionated by polyacrylamide gel electrophoresis. Specific applications of this novel assay include structural characterization of glycoproteins, diagnosis of mucolipidosis II and III, and screening of pharmaceuticals for lysosomotropic activity. Other potential applications are discussed.
UR - http://www.scopus.com/inward/record.url?scp=0027536273&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027536273&partnerID=8YFLogxK
U2 - 10.1006/abio.1993.1096
DO - 10.1006/abio.1993.1096
M3 - Article
C2 - 8465950
AN - SCOPUS:0027536273
SN - 0003-2697
VL - 209
SP - 156
EP - 162
JO - Analytical Biochemistry
JF - Analytical Biochemistry
IS - 1
ER -